Print

Print


Janet,
Thanks for the post.  I've printed it out and plan to leave it laying out for my
husband to "discover".  Maybe, just maybe he will pick it up and take a look!

Couldn't hurt!

Claudia

Janet Paterson wrote:

> "re-re-post"
>
> hello cyber-siblings
>
> there seems to be a flock of new members on the list [siblets?]
> and i thought it might be helpful to re-post this article
> since there were so many positive reactions last time
>
> your psycho-social cyber-sis
> janet
> original posted 970919
> ------------------------------------------------------------
> Psychosocial Factors in the Treatment of Parkinson's Disease:
> A Contextual Approach
> ------------------------------------------------------------
> by
> Robert G. Feldman, M.D.,
> Peter Mosbach, Ph.D.,
> Cathi-Ann Thomas, R.N., M.S., and
> Linda M. Perry, R.N., M.Ed.
> This is an excerpt of Chapter 14 from the book
> The Comprehensive Management of Parkinson's Disease, 1995
> Demos Vermande Publications, 386 Park Avenue, New York, NY 10016
> ------------------------------------------------------------
> Parkinson's disease (PD) becomes an unavoidable intrusion in the life of
> the affected person and others with whom s/he is involved.
> The impairments in daily functioning of the patient and the changes in each
> family member's concept of her/his life's plan result in the realization
> that treatment of Parkinson's disease requires more from the health care
> team than the recognition of the signs and symptoms, making a diagnosis,
> and prescribing medication.
> Each person with Parkinson's disease has her/his unique experience, which
> deserves an individualized treatment plan.
> What is universal, however, is the need for each person to know as much as
> possible about the condition and how certain insights. anticipations, and
> adjustments lead to more effective living with Parkinson's disease.
> Since the individual with Parkinson's disease is a member of several
> networks (family, social, work), her/his malady also becomes a problem for
> these people.
> A better understanding of Parkinson's disease by everyone concerned will
> result in more effective coping, proper long-term management, and a more
> successful therapeutic outcome.
> Members of the health care team, including the neurologist, must appreciate
> that a diagnosis exists in the context of all other aspects of the
> patient's life.
> At each stage in the progression of the illness, the patient deals with
> actual and perceived losses, that require special considerations and place
> unique burdens on the patient, members of her/his family, the physician,
> and members of the healthcare team.
> A principal goal for all caregivers is to understand the impact of the
> disease and to anticipate the needs of the patient and her/his family by
> guiding them to helpful solutions throughout the course of Parkinson's
> disease.
> The condition does not go away after the diagnosis is made.
> The formalization of a diagnostic label triggers inevitable reactions and
> thoughts that alter the patient's prior conception of her/his life's plan.
> ------------------------------------------------------------
> The Coping Process
> ------------------------------------------------------------
> The complexity of Parkinson's disease presents numerous stresses that need
> to be addressed by the patient and her/his family.
> Some individuals are able to utilize techniques successfully to deal with
> various stresses on a daily basis.
> Others, who have not developed an effective set of mental mechanisms for
> adapting to changing environmental (external) demands in order to meet
> personal (internal) needs. have the greatest difficulty accepting the
> diagnosis of Parkinson's disease.
> They refuse to accept or 'own' the problem and become a 'victim' of this
> malady.
> They may attempt to place the responsibility for their treatment on family
> members and health care providers.
> Coping is the capacity to successfully manage an actual or potential
> problem by recognizing the need for adjustment and achieving it, and
> requires cognitive and behavioral efforts to master, tolerate, reduce, or
> minimize internal and external demands, and the conflicts among them.
> Long-term management of Parkinson's disease is usually more successful in
> the patient who previously has had effective techniques for coping with
> stressful life events; for those who have not, it is the responsibility of
> each health care provider to assist in the coping process through the use
> of multiple approaches.
> The patient with Parkinson's disease must develop and retain a sense of
> control over her/his life's plan.
> S/he needs to learn how to plan daily activities around the duration of
> action of medications and not be 'surprised' by the unpredictability of the
> effectiveness of their pharmacological treatment.
> Additionally, the patient must have information about the illness,
> including symptoms, prognosis, and available alternative treatments.
> The perception of having control diminishes the likelihood of becoming a
> victim and reduces the sense of hopelessness that accompanies a state of
> dependence.
> Presented with information about her/his illness, a patient may initially
> find it stress-inducing, but those who have access to such information
> about their illness become active partners in managing their case with
> members of the health care team and have better long-term outcomes than
> patients who do not have access to such information.
> ------------------------------------------------------------
> The Assessment Process
> ------------------------------------------------------------
> In order to better understand the psychosocial stresses facing an
> individual with Parkinson's disease and to formulate an effective
> intervention plan, it is crucial to conduct a comprehensive assessment of
> the patient, her/his spouse or significant other, the primary caregiver, as
> well as children or parents.
> In this way, all those affected directly or indirectly share similar
> information upon which to construct a treatment and support plan.
> It is important at the onset of treatment for the patient to learn that
> helping her/him to most effectively deal with Parkinson's disease requires
> the assistance, understanding, and cooperation of other members of their
> social network. Trying to 'keep it a secret' only impedes the adjustment
> process.
> The patient and her/his disease must be considered in the context of the
> patient's concept of disease, the family environment, educational and work
> background, premorbid personality and life-style, and approaches to problem
> solving.
> ------------------------------------------------------------
> Patient's Concept of the Disease
> ------------------------------------------------------------
> Many patients with Parkinson's disease may recall observing friends,
> relatives, or acquaintances during the pre L-dopa era when there was no
> effective treatment for Parkinson's disease.
> Individuals with this disorder frequently had significant levels of
> disability, a potentially frightening image to an observer. Such memories
> may affect the patient's mental model of Parkinson's disease, as they may
> initially perceive it as a disabling and untreatable illness.
> A patient's cognitive model or preconceived notions of higher illness or
> treatment is often inconsistent with medical reality, and their beliefs may
> lead to added stress and ineffective coping strategies.
> It is, therefore, important to assess the patient's concept of her/his own
> condition.
> Although patients with Parkinson's disease share many common
> characteristics, the impact of each symptom on an individual patient's life
> may be vastly different. What is important to one patient may not be
> important to another.
> An inventory should be made of those specific activities the patient finds
> difficult to perform, those that interfere with her/his ability to perform
> work tasks, or those that alter higher physical appearance.
> A specifically perceived disability becomes a 'target for therapy' to be
> used as the outcome measure of efficacy of treatment.
> Improvement after doses of medication or after therapeutic intervention can
> be looked for in areas of functioning, such as disturbances of motor
> control, gait, posture, arm swing, bimanual tasks, eating, dressing,
> impaired socialization, facial expression, volume of voice, conversational
> interaction, and depression.
> Reaching agreement with the patient and their family about the priority of
> given targets of therapy ('things to be fixed') enables the physician,
> therapists, and patient to share the expected goals of specific medication
> dosages and therapy interventions.
> Lack of agreement about this may result in misunderstanding and
> disappointment, since the total 'cure' may not be achieved as anticipated
> by everyone.
> The patient and her/his family also usually have a concept of what they
> expect from the physician and other members of the health care team.
> Among those expectations is that the physician will listen to the patient
> and respect her/his input about the condition and will invite active
> participation in decision making.
> ------------------------------------------------------------
> Family Environment
> ------------------------------------------------------------
> It is also important to assess the patient's relationship and geographic
> proximity to other relatives such as parents, children, and siblings.
> The availability of family members who are able to provide both practical
> assistance and emotional support is one of the best predictors of success
> in effectively managing a chronic and progressive illness such as
> Parkinson's disease.
> Family interactions become especially important to the patient when
> embarrassment about symptoms leads to social withdrawal and leaves patients
> with family members as their primary source of social contact.
> The intensity of familial relationships increases proportionally in
> importance as level of disability increases.
> The strength of familial relationships and clarity of interpersonal
> communication are severely tested by stress later in the disease process.
> ------------------------------------------------------------
> Educational and Work History
> ------------------------------------------------------------
> The physician and other members of the health care team can use the
> educational background or vocational interests of the patient to improve
> communication and thus enhance the understanding of information presented
> to the patient in regard to their treatment and prognosis.
> It is useful to explain the disease process and treatment approaches in an
> appropriate frame of reference to which the patient can relate, using
> analogies, metaphors, and diagrams, rather than highly scientific jargon
> comprehensible only to the 'insider' health care professional.
> When communicating with a patient, never assume prior knowledge, regardless
> of the patient's profession or education level.
> A patient seeks explanations, directions, and coaching, and it is often the
> most sophisticated patients who need the most explicit directions,
> reassurance, and support.
> ------------------------------------------------------------
> Premorbid Personality and Coping Style
> ------------------------------------------------------------
> Previous studies have suggested that patients with Parkinson's disease have
> a specific premorbid personality and coping style.
> In a study of identical twins discordant for the illness, the twin with
> Parkinson's disease was more anxious than the undiagnosed sibling. Patients
> with Parkinson's disease have often been described as tense,
> overcontrolled, and having a perfectionist character style.
> For patients with Parkinson's disease who have an obsessive-compulsive
> personality type, their coping style is often reflected by an obsession
> about their medications. In particular, such patients are often fanatical
> about the time they take their medications. Such compulsion about the pills
> and the 'clock' needs to be recognized as that patient's particular attempt
> to cope and to retain control of her/his environment and circumstances.
> Coping strategies can be divided into two types:
> (1) problem-solving responses,
> which are aimed at changing conditions of the situation, and
> (2) emotion-focused responses,
> which are intended to reduce the person's unpleasant or fearful feelings
> about themselves and aspects of their situation that they cannot change.
> Effective coping usually involves both problem-solving and emotion-focused
> strategies.
> ------------------------------------------------------------
> Coping Needs in Different Stages of Parkinson's Disease
> ------------------------------------------------------------
> Individualization of Therapy
> Each patient and family member will have different medical and psychosocial
> needs depending on medical history, family history, level of psychological
> functioning, and history of how well they have previously coped with stress.
> >From the initial contact with the treating neurologist, the importance of
> accepting responsibility for her/his condition is emphasized to the patient.
> We encourage the acquisition of as much knowledge as possible about her/his
> Parkinson's disease and its treatment, so that s/he becomes an active
> partner in the treatment and becomes a 'non-victim'.
> Therapy for the patient with Parkinson's disease must be individualized to
> reflect the stage of progression of the disease.
> ------------------------------------------------------------
> The Early Stages and Previously Untreated Patients
> ------------------------------------------------------------
> The previously untreated patient comes to the neurologist with great
> anxiety.
> The stress of the disease actually begins before the formal diagnosis of
> Parkinson's disease is made, as many patients note changes in their body
> and subtle impairments long before presenting to a physician.
> Some patients exhibit reduced facial expression and overall loss of energy
> and are often initially diagnosed as having depression.
> It may take one or more years of physician visits before a diagnosis of
> Parkinson's disease is established. During the time of uncertainty,
> patients may experience, for example, a fear of having a brain tumor.
> For some patients, a definitive diagnosis of Parkinson's disease serves as
> a relief that they do not have a more serious or potentially fatal
> disorder. It can also be a relief to receive an explanation for their
> symptoms.
> When initially diagnosed with Parkinson's disease, most patients have lithe
> knowledge of the disease and do not know what to expect.
> Some patients have simply been told, 'You have Parkinson's disease, here is
> your prescription, come back for an appointment in six months'. This can be
> a distressing experience for many patients who feel overwhelmed and
> intimidated by the neurologist and are reluctant to ask questions.
> Personal discussion with a neurologist and nurse practitioner is absolutely
> necessary in the period following the initial diagnosis of Parkinson's
> disease.
> Reading generic articles about Parkinson's disease may be frightening for
> the early stage patient; therefore, carefully selected written materials
> appropriate to the stage and particular areas of concern should be provided
> to the patient and her/his family.
> Several patients with Parkinson's disease have written very useful books
> about their personal experiences with the disease. They may be beneficial
> for the newly diagnosed patient as they provide insights not available
> elsewhere.
> One example is 'Living Well with Parkinson's', by Glenna Atwood. which
> provides a clear account of the author's struggle and successes encountered
> throughout her years with Parkinson's disease. It is accurate and frank,
> yet personal and helpful.
> Pamphlets published by patient support organizations and pharmaceutical
> companies can also be informative.
> Patients are encouraged to join lay support organizations such as the
> American Parkinson's Disease Association (APDA), the United Parkinson's
> Disease Foundation (UPF), and the National Parkinson Foundation (NPF). By
> joining these organizations, patients are able to receive current
> information about developments pertaining to Parkinson's disease.
> Newly diagnosed patients are encouraged to become active in support groups
> appropriate to their age and stage of illness and to share experiences with
> others.
> At the early stages of Parkinson's disease, most individuals are physically
> and cognitively able to continue participating in nearly all social,
> vocational, and recreational activities.
> Some patients tend to withdraw from activities due to embarrassment about
> their symptoms, especially tremor. In the early stages of their illness,
> some patients are afraid to let others know that they have Parkinson's
> disease, and they devote significant effort to hiding their symptoms.
> Attempting to conceal symptoms can lead to increased anxiety, which in turn
> can cause an increase in the symptoms of Parkinson's disease.
> Those patients who have been able to inform others about their illness, its
> symptoms, and treatment tend to be the individuals who cope best at the
> early stages.
> Case summaries of two individuals with an early stage parkinsonism who used
> vastly different strategies in terms of coping with their Parkinson's
> disease illustrate this issue.
> Both of these individuals were college professors in their late fifties.
> The first person readily accepted her Parkinson's disease.
> She often took the opportunity to tell others about it and emphasized that
> it was not a major issue for her.
> In this example, the patient used the emotional strategy of coping by
> accepting her condition.
> On the first day of the semester, she would inform her class 'I have
> Parkinson's disease. It is usually well controlled by the medications I am
> taking, but some days you may notice that I have tremor or that I may have
> difficulty writing on the blackboard. I hope you will be understanding
> about this.'
> She found that once she told the students about her Parkinson's disease and
> did not appear distressed about it, her ailment was no longer an issue for
> her or for the class.
> In contrast, the second patient was frightened that others would find out
> about his Parkinson's disease.
> He tried to alter his environment in order to hide his symptoms, a coping
> mechanism that proved less than successful.
> When lecturing to his classes, he would arrange to speak from behind a
> lectern so that his tremulous hands were out of sight of the audience.
> He faced each lecture with a high level of anxiety that only interfered
> with his ability to give a lecture and exacerbated his Parkinson's disease
> symptoms.
> Nondisclosure of symptoms increases the stress of the illness and
> interferes with successful adaptation needed for managing Parkinson's
> disease.
> Individuals who use denial or avoidance as a primary coping strategy are
> most likely to attempt to conceal their diagnosis from others.
> At early stages of Parkinson's disease, this strategy may actually work for
> a period of time, but this strategy usually fails as the illness progresses.
> Social withdrawal due to embarrassment about early stage symptoms of
> Parkinson's disease has been a major issue for many patients. Those
> patients who withdraw from their usual social and recreational activities
> are most likely to experience depression.
> Depression is a common accompaniment of Parkinson's disease. In the early
> and middle stages of Parkinson's disease, the level of depression is a
> function of self-appraisal processes.
> The best predictor of depression is a person's self-rating of her/his own
> disability. Self-appraisal processes and the use of appropriate coping
> strategies can reduce the degree of emotional distress that a patient
> experiences.
> ----------------------------------------------------------------------
>
> janet paterson / 50-9 / sinemet-selegiline-prozac / [log in to unmask]